Lung Cancer Policy Network shared a post on LinkedIn:
“We know that detecting lung cancer earlier improves survival. So why are so many people still diagnosed at a late stage?
Low‑dose computed tomography (LDCT) screening is a proven, cost-effective approach to detecting lung cancer earlier in people at highest risk. Yet access and implementation remain uneven – and in some places, absent entirely.
We’ve refreshed our factsheets to support advocates engaging with policymakers as they design or expand LDCT screening programs, helping close this implementation gap and translate evidence into action.”
Other articles about LDCT on OncoDaily.